Published in J Pathol on April 01, 1987
Review: assessment of cell proliferation in histological material. J Clin Pathol (1990) 2.41
p53 expression in colorectal tumors. Am J Pathol (1991) 1.77
p53 in colorectal cancer: clinicopathological correlation and prognostic significance. Br J Cancer (1991) 1.70
c-Ki-ras gene mutations in dysplasia and carcinomas complicating ulcerative colitis. Br J Cancer (1991) 1.61
Prognostic indicators in centroblastic-centrocytic lymphoma. J Clin Pathol (1988) 1.41
Do aggressive subclones within primary colorectal cancer give rise to liver metastases? Int J Colorectal Dis (1989) 1.10
Survival of large bowel carcinoma patients with different DNA ploidy. Br J Cancer (1987) 1.01
Clinical importance of DNA content in rectal cancer measured by flow cytometry. J Clin Pathol (1989) 0.95
An investigation of different methods of cell cycle analysis by flow cytometry in rectal cancer. Br J Cancer (1992) 0.91
The prognostic value of nucleolar organiser regions in colorectal cancer: a 5-year follow-up study. Ann R Coll Surg Engl (1992) 0.90
The prognostic value of DNA-ploidy in colorectal carcinoma: a prospective study. Br J Cancer (1990) 0.89
Intra-tumoral heterogeneity of tumour potential doubling times (Tpot) in colorectal cancer. Br J Cancer (1993) 0.89
Tumor DNA content in resectable, primary colorectal carcinoma. Ann Surg (1989) 0.88
DNA aneuploidy and cell proliferation in familial adenomatous polyposis. Gut (1988) 0.87
The influence of tumour cell DNA content on survival in colorectal cancer: a detailed analysis. Br J Cancer (1990) 0.83
Cell kinetics: an independent prognostic variable in stage II melanoma of the skin. Br J Cancer (1990) 0.78
DNA index and S-phase fraction in curative resection of colorectal adenocarcinoma: analysis of prognosis and current trends. World J Surg (2002) 0.77
Flow cytometry in colon cancer: does flow cytometric cell cycle analysis help predict for short-term recurrence in patients with colorectal carcinoma? J Natl Med Assoc (1995) 0.77
Flow cytometric analysis in colorectal carcinoma: prognostic significance of cellular DNA content. Int J Colorectal Dis (1990) 0.77
Flow cytometric analysis of ploidy in colorectal cancer: a multicentric experience. Br J Cancer (1993) 0.76
Carcinoma of the anal canal and flow cytometric DNA analysis. Br J Cancer (1989) 0.76
DNA ploidy in bronchopulmonary carcinoid tumours. Thorax (1988) 0.76
DNA densitometry of colorectal cancer. Gut (1993) 0.76
Anastomosis or stoma for low rectal cancer? Postgrad Med J (1989) 0.75
Genetics of colon cancer. West J Med (1991) 0.75
Prognostic significance of the bromodeoxyuridine labeling index in primary colorectal carcinoma. Surg Today (1997) 0.75
Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature (1993) 10.72
Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet (1986) 10.07
The Vienna classification of gastrointestinal epithelial neoplasia. Gut (2000) 9.39
A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology (1997) 7.72
Screening dyspepsia by serology to Helicobacter pylori. Lancet (1991) 6.13
Unacceptable variation in abdominoperineal excision rates for rectal cancer: time to intervene? Gut (2008) 5.86
Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet (1994) 5.86
Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study. Br J Cancer (2001) 5.36
Gastric cancer: a curable disease in Britain. BMJ (1993) 4.24
Direct polymerase chain reaction test for detection of Helicobacter pylori in humans and animals. J Clin Microbiol (1991) 3.91
WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc Natl Acad Sci U S A (1998) 3.73
Gastric dysplasia: the Padova international classification. Am J Surg Pathol (2000) 3.66
Five-year follow-up of the Medical Research Council CLASICC trial of laparoscopically assisted versus open surgery for colorectal cancer. Br J Surg (2010) 3.63
Tissue extraction of DNA and RNA and analysis by the polymerase chain reaction. J Clin Pathol (1990) 3.30
Flat and depressed colonic neoplasms: a prospective study of 1000 colonoscopies in the UK. Lancet (2000) 3.23
Campylobacter pyloridis and acid induced gastric metaplasia in the pathogenesis of duodenitis. J Clin Pathol (1987) 3.21
Cost effectiveness of antenatal screening for cystic fibrosis. BMJ (1995) 3.05
Surgical management and outcomes of colorectal cancer liver metastases. Br J Surg (2010) 3.03
Consequences of the provision of laboratory services for the National Health Service by commercial firms: a view from the university sector. J Clin Pathol (1990) 2.99
Guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflammatory bowel disease. The British Society of Gastroenterology Initiative. J Clin Pathol (1997) 2.98
Long-term follow-up of the Medical Research Council CLASICC trial of conventional versus laparoscopically assisted resection in colorectal cancer. Br J Surg (2012) 2.93
KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program. Virchows Arch (2008) 2.78
Unlocking the archive--gene expression in paraffin-embedded tissue. J Pathol (2001) 2.76
A randomized trial on root caries prevention in elders. J Dent Res (2010) 2.74
Reflux gastritis: distinct histopathological entity? J Clin Pathol (1986) 2.73
Choice of management strategy for colorectal cancer based on a diagnostic immunohistochemical test for defective mismatch repair. Gut (1999) 2.68
Identification of Helicobacter pylori DNA in the mouths and stomachs of patients with gastritis using PCR. J Clin Pathol (1993) 2.60
Observer variation in the histological grading of rectal carcinoma. J Clin Pathol (1983) 2.59
Bacterial adhesion and disease activity in Helicobacter associated chronic gastritis. Gut (1990) 2.58
Immunogold-silver staining: new method of immunostaining with enhanced sensitivity. J Histochem Cytochem (1983) 2.57
Local recurrence of colorectal cancer: the problem, mechanisms, management and adjuvant therapy. Br J Surg (1994) 2.43
Frequency of patients' consulting in general practice and workload generated by frequent attenders: comparisons between practices. Br J Gen Pract (1998) 2.37
Chronic gastritis--a pathogenetic approach. J Pathol (1988) 2.31
Histological identification of Helicobacter pylori: comparison of staining methods. J Clin Pathol (2000) 2.31
Effect of duodenal ulcer surgery and enterogastric reflux on Campylobacter pyloridis. Lancet (1986) 2.27
Multicentre experience with extralevator abdominoperineal excision for low rectal cancer. Br J Surg (2010) 2.23
Aids and adaptations for the elderly at home: underprovided, underused, and undermaintained. Br Med J (Clin Res Ed) (1988) 2.21
An analysis of the reliability of detection and diagnostic value of various pathological features in Crohn's disease and ulcerative colitis. Gut (1973) 2.21
The effect of pH and temperature on the kinetic parameters of phosphoglucose isomerase. Participation of histidine and lysine in a proposed dual function mechanism. J Biol Chem (1968) 2.21
Genetic abnormalities during transition from Helicobacter-pylori-associated gastritis to low-grade MALToma. Lancet (1995) 2.21
Reappraisal of the 5 centimetre rule of distal excision for carcinoma of the rectum: a study of distal intramural spread and of patients' survival. Br J Surg (1983) 2.17
Early gastric cancer: 46 cases treated in one surgical department. Gut (1992) 2.10
Colorectal tumour deposits in the mesorectum and pericolon; a critical review. Histopathology (2007) 2.01
One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group. Gut (1997) 2.00
Campylobacter-like organisms unusual in type A (pernicious anaemia) gastritis. Lancet (1984) 2.00
PCR identification of Helicobacter pylori in faeces from gastritis patients. Lancet (1993) 2.00
Campylobacter like organisms and reflux gastritis. J Clin Pathol (1986) 1.99
Butyrate oxidation is impaired in the colonic mucosa of sufferers of quiescent ulcerative colitis. Gut (1994) 1.96
Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther (2002) 1.94
Rapid detection of allele loss in colorectal tumours using microsatellites and fluorescent DNA technology. Br J Cancer (1993) 1.93
Microsatellite instability in colorectal cancer: improved assessment using fluorescent polymerase chain reaction. Gastroenterology (1995) 1.92
Accuracy of reporting of family history of colorectal cancer. Gut (2004) 1.92
Flat adenomas in the United Kingdom: are treatable cancers being missed? Endoscopy (1998) 1.92
Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 gene. Oncogene (1994) 1.91
Restorative proctocolectomy with ileal reservoir. Int J Colorectal Dis (1986) 1.91
Microsatellite instability and the role of hMSH2 in sporadic colorectalcancer. Oncogene (1996) 1.89
Bladder and sexual function following resection for rectal cancer in a randomized clinical trial of laparoscopic versus open technique. Br J Surg (2005) 1.89
Failure of colonoscopic surveillance in ulcerative colitis. Gut (1993) 1.82
Vanilloid receptor 1 immunoreactivity in inflamed human bowel. Lancet (2001) 1.79
p53 expression in colorectal tumors. Am J Pathol (1991) 1.77
Parastomal hernia prevention using a novel collagen implant: a randomised controlled phase 1 study. Hernia (2008) 1.76
Sensory fibres expressing capsaicin receptor TRPV1 in patients with rectal hypersensitivity and faecal urgency. Lancet (2003) 1.74
The prediction of local recurrence in rectal adenocarcinoma by histopathological examination. Int J Colorectal Dis (1988) 1.72
Ileal ecology after pouch-anal anastomosis or ileostomy. A study of mucosal morphology, fecal bacteriology, fecal volatile fatty acids, and their interrelationship. Gastroenterology (1989) 1.71
De-functioning stomas: a prospective controlled trial comparing loop ileostomy with loop transverse colostomy. Br J Surg (1986) 1.71
p53 in colorectal cancer: clinicopathological correlation and prognostic significance. Br J Cancer (1991) 1.70
MALToma-like lesions in the murine gastric mucosa after long-term infection with Helicobacter felis. A mouse model of Helicobacter pylori-induced gastric lymphoma. Am J Pathol (1995) 1.70
Ki-ras mutations in adenomas: a characteristic of cancer-bearing colorectal mucosa. J Pathol (1996) 1.70
The rationale behind complete mesocolic excision (CME) and a central vascular ligation for colon cancer in open and laparoscopic surgery : proceedings of a consensus conference. Int J Colorectal Dis (2014) 1.69
p53 dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following gamma-irradiation. Oncogene (1994) 1.69
DNA markers predicting benefit from adjuvant fluorouracil in patients with colon cancer: a molecular study. Lancet (2002) 1.68
Gastric epithelium in the duodenum: its association with Helicobacter pylori and inflammation. J Clin Pathol (1990) 1.68
The Sydney System revisited: the Houston International Gastritis Workshop. Am J Gastroenterol (1995) 1.68
Circumferential margin involvement after mesorectal excision of rectal cancer with curative intent. Predictor of survival but not local recurrence? Dis Colon Rectum (1998) 1.66
Levels of nitrite, nitrate, N-nitroso compounds, ascorbic acid and total bile acids in gastric juice of patients with and without precancerous conditions of the stomach. Carcinogenesis (1991) 1.64
Childhood cancer and overhead powerlines: a case-control study. Br J Cancer (1990) 1.62
Effects of Helicobacter pylori eradication on the natural history of lymphocytic gastritis. Gut (1999) 1.62
Methylation and colorectal cancer. J Pathol (2001) 1.61
c-Ki-ras gene mutations in dysplasia and carcinomas complicating ulcerative colitis. Br J Cancer (1991) 1.61
Mast cells are closely apposed to nerves in the human gastrointestinal mucosa. Gastroenterology (1989) 1.61
Factors influencing bowel function after ileal pouch-anal anastomosis. Br J Surg (1986) 1.60
Bile reflux and intestinal metaplasia in gastric mucosa. J Clin Pathol (1993) 1.60
The Clinical Anxiety Scale: an instrument derived from the Hamilton Anxiety Scale. Br J Psychiatry (1982) 1.60